Back to mobile site

Mizuho Reiterates Buy Rating on Allergan (AGN) Ahead of Earnings

February 7, 2017 6:26 AM EST Send to a Friend
Mizuho Securities analyst Irina Koffler maintains Buy rating and $273 price target on Allergan PLC (NYSE: AGN) ahead ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login